2023
DOI: 10.1371/journal.pone.0287198
|View full text |Cite
|
Sign up to set email alerts
|

Albendazole repurposing on VEGFR-2 for possible anticancer application: In-silico analysis

Abstract: Drug repurposing is the finding new activity of the existing drug. Recently, Albendazole’s well-known antihelmintic has got the attention of an anticancer drug. Plausible evidence of the interaction of Albendazole with one of the types of tyrosine kinase protein receptor, vascular endothelial growth factor receptor-2 (VEGFR-2) is still not well understood. Inhibition of the VEGFR-2 receptor can prevent tumor growth. The current study investigated the interaction of Albendazole with VEGFR-2.It was found that th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 28 publications
0
2
0
Order By: Relevance
“…A production run was completed for a period of 100 ns. The resulting MD trajectories were statistically analyzed. , …”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…A production run was completed for a period of 100 ns. The resulting MD trajectories were statistically analyzed. , …”
Section: Methodsmentioning
confidence: 99%
“…The resulting MD trajectories were statistically analyzed. 72,73 ■ ASSOCIATED CONTENT * sı Supporting Information…”
mentioning
confidence: 99%